Pharmacy Technicians with an Interest in Immunotherapy

The BOPA Specialist Advisory Group for Immunotherapy (IO SAG), has recently reviewed its membership and identified a gap in terms of pharmacy technician representation.

With the expanding roles of clinical pharmacy technicians in terms of clinical verification of SACT and easing of workforce pressures, we would be very keen to have technicians represented on the IO SAG.

We are very friendly group who meet on teams every 2 months. In addition, we are meeting face to face at this years’ conference and would invite any technicians to come along and see whether you would like to be involved.

Sat 12th October. Media Suite 1555-1630.

In addition, any new pharmacists interested in getting involved in our workstream are also welcome!

Meera and I co-chair the group, so please also contact us directly if you would like any further information.

Kind Regards

Alice Tew: alice.tew@uhb.nhs.uk

Meera Desai: [email protected]

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article